183 results on '"McCarthy, William F."'
Search Results
2. Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea
3. Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
4. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program follow-up study
5. Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
6. Multidetector Computed Tomography Myocardial Perfusion Imaging During Adenosine Stress
7. WITHDRAWN: Managing Environmental Compliance: A Study of Expansion, Replacement and Integrity Projects
8. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO angiographic experience
9. The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients
10. Early Detection of Responders to Hydroxyurea Therapy: 030
11. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: Effect of sex, age, and geographical location
12. Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
13. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
14. Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
15. Effect of Geography and Climate on Pain Frequency in Patients Enrolled in the Muticenter Study of Hydroxyurea in Sickle Cell Anemia: # 253
16. Age-specific reference ranges for serum prostate-specific antigen in black men
17. Diocesan asset management strategies: the civil law perspective.
18. Predictors of left ventricular function after acute myocardial infarction: Effects of time to treatment, patency, and body mass index: The GUSTO-I angiographic experience
19. Topical paromomycin for New World cutaneous leishmaniasis
20. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix: a clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors
21. Pleomorphic (spindle/giant cell) carcinoma of the lung: a clinicopathologic correlation of 78 cases
22. Prognostic factors in pulmonary fibrohistiocytic lesions
23. Comparison of cardiac findings in patients with mitral valve prolapse who die suddenly to those who have congestive heart failure from mitral regurgitation and to those with fatal noncardiac conditions
24. M.S.A.D. 11 Adult Education for the Handicapped.
25. Multivariate Models for Predicting Progression to AIDS and Survival in Human Immunodeficiency Virus-Infected Persons
26. Racial Differences in Serum β₂-Microglobulin in Persons with Human Immunodeficiency Virus Infection
27. Evaluation of Computer Assisted Telephone Interviewing as a Survey Methodology by Means of Cost Models and Mathematical Programming
28. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
29. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
30. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
31. Evaluation of Computer Assisted Telephone Interviewing as a Survey Methodology by Means of Cost Models and Mathematical Programming
32. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area
33. Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
34. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
35. Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home
36. Early Detection of Response to Hydroxyurea Therapy in Patients with Sickle Cell Anemia
37. Footprints of Response to Hydroxyurea Are in the Hemogram.
38. Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
39. Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).
40. Definition of the Responder to Hydroxyurea Therapy: Revisited.
41. Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.
42. Time Series Analysis of the Pain Diary Data Obtained during the Multicenter Study for Hydroxyurea (MSH) Clinical Trial.
43. Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study
44. 858: A Comparison of Two Grading Systems in Predicting Stage
45. Managing Environmental Compliance: A Study of Expansion, Replacement and Integrity Projects.
46. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic antimalarials in non-immune individuals during deployment to a malaria-endemic area.
47. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience
48. Statement of William F. McCarthy, Ph.D.
49. Don't blow it
50. HMB45 Negative Spindle Cell Malignant Melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.